-
公开(公告)号:EP2861583B1
公开(公告)日:2016-06-29
申请号:EP13725533.7
申请日:2013-05-17
IPC分类号: C07D239/42 , C07D239/70 , C07D403/04
CPC分类号: C07D239/70 , C07D239/42 , C07D403/04
-
公开(公告)号:EP2861582B1
公开(公告)日:2016-05-25
申请号:EP13725042.9
申请日:2013-05-17
发明人: ASKIN, David , HAN, Chong , LANE, Jonathan W. , REMARCHUK, Travis , SHAKYA, Sagar , SOWELL, C. Gregory , SPENCER, Keith L. , STENGEL, Peter J.
IPC分类号: C07D239/42 , C07D239/70 , C07D403/04
CPC分类号: C07D239/42 , C07D239/30 , C07D239/70 , C07D403/04
摘要: The invention provides processes for preparing a compound of formula I and salts thereof, wherein R1 is defined herein, and compounds and intermediates of said formula.
-
公开(公告)号:EP2861583A1
公开(公告)日:2015-04-22
申请号:EP13725533.7
申请日:2013-05-17
IPC分类号: C07D403/04
CPC分类号: C07D239/70 , C07D239/42 , C07D403/04
摘要: The invention provides new processes for making and purifying hydroxylated cyclopenta[d]pyrimidine compounds, which are useful for the treatment of diseases such as cancer as AKT protein kinase inhibitors, including the compound (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one.
摘要翻译: 本发明提供了制备和纯化羟基化环戊二烯并[d]嘧啶化合物的新方法,其可用于治疗诸如癌症的疾病,如AKT蛋白激酶抑制剂,包括化合物(S)-2-(4-氯苯基)-1 - (4 - ((5R,7R)-7-羟基-5-甲基-6,7-二氢-5H-环戊二烯并[d]嘧啶-4-基)哌嗪-1-基)-3-(异丙基氨基)丙 -1-之一。
-
公开(公告)号:EP3036227B1
公开(公告)日:2020-01-08
申请号:EP14838336.7
申请日:2014-08-21
发明人: HAN, Chong , GREEN, Keena , GOSSELIN, Francis , SCALONE, Michelangelo , NICHOLS, Paul J. , LIU, Weidong , STENGEL, Peter J. , SHAKYA, Sagar , CRANE, Zackary D. , SPENCER, Keith L.
IPC分类号: C07D401/00 , C07D403/00
-
公开(公告)号:EP3262042A1
公开(公告)日:2018-01-03
申请号:EP16709228.7
申请日:2016-02-26
发明人: STULTS, Jeffrey , LINDEMANN, Christopher M. , SPENCER, Keith L. , LIU, Weidong , LUBACH, Joseph
IPC分类号: C07D471/04 , A61K31/437 , A61P35/00
CPC分类号: C07D471/04 , A61K31/437 , A61K45/06
摘要: Disclosed are crystalline forms of (R)—N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide, and salts, solvates, and hydrates thereof, and pharmaceutical compositions, formulations and a process of manufacturing thereof.
-
公开(公告)号:EP3036227A1
公开(公告)日:2016-06-29
申请号:EP14838336.7
申请日:2014-08-21
发明人: HAN, Chong , GREEN, Keena , GOSSELIN, Francis , SCALONE, Michelangelo , NICHOLS, Paul J. , LIU, Weidong , STENGEL, Peter J. , SHAKYA, Sagar , CRANE, Zackary D. , SPENCER, Keith L.
IPC分类号: C07D401/00 , C07D403/00
摘要: The invention provides processes of preparation thereof useful in the preparation of compounds that can be used as CHK1 inhibitors.
-
公开(公告)号:EP2861582A1
公开(公告)日:2015-04-22
申请号:EP13725042.9
申请日:2013-05-17
发明人: ASKIN, David , HAN, Chong , LANE, Jonathan W. , REMARCHUK, Travis , SHAKYA, Sagar , SOWELL, C. Gregory , SPENCER, Keith L. , STENGEL, Peter J.
IPC分类号: C07D403/04
CPC分类号: C07D239/42 , C07D239/30 , C07D239/70 , C07D403/04
摘要: The invention provides processes for preparing a compound of formula I and salts thereof, wherein R1 is defined herein, and compounds and intermediates of said formula.
摘要翻译: 本发明提供制备式I化合物及其盐的方法,其中R 1如本文所定义,以及所述式的化合物和中间体。
-
-
-
-
-
-